What Happened
- India's chief trade negotiator has postponed a scheduled visit to Washington D.C. to finalise the legal text of an interim trade deal with the United States.
- The pause follows a landmark ruling by the US Supreme Court on February 20, 2026, in Learning Resources, Inc. v. Trump, which struck down the Trump administration's use of the International Emergency Economic Powers Act (IEEPA) to impose country-specific "reciprocal" tariffs.
- In response, Trump invoked Section 122 of the Trade Act of 1974, first imposing a 10% global tariff, then raising it to 15%, effective February 24, 2026, for up to 150 days (expiring around late July 2026).
- India had been facing a 25% reciprocal tariff, with an interim deal nearly concluded that would have reduced it to 18%. The new 15% global tariff now changes the calculus.
- The Global Trade Research Initiative (GTRI) urged India to reassess the deal, as the proposed interim terms may now be more burdensome than simply accepting the new 15% global baseline plus India's ~3% Most Favoured Nation (MFN) rate (combined ~18.4%).
- Commerce Minister Piyush Goyal had previously indicated an interim deal would be signed by March and become effective from April 2026.
Static Topic Bridges
The US Supreme Court Ruling — Learning Resources, Inc. v. Trump (2026)
On February 20, 2026, the US Supreme Court ruled 6-3 that the International Emergency Economic Powers Act (IEEPA) does not authorise the President to impose tariffs. Chief Justice John Roberts, writing for the majority (joined by Justices Sotomayor, Kagan, Gorsuch, Barrett, and Jackson), held that "IEEPA contains no reference to tariffs or duties" and that the statute's text cannot bear the weight of such expansive executive authority.
- Case: Learning Resources, Inc. v. Trump, 607 U.S. ___ (2026); decided February 20, 2026
- Vote: 6-3 (Roberts, Sotomayor, Kagan, Gorsuch, Barrett, Jackson for majority; Thomas, Kavanaugh, Alito in dissent)
- IEEPA (International Emergency Economic Powers Act, 1977): Grants the President authority to regulate international commerce during national emergencies — but the court ruled tariffs are not within this authority
- Financial impact: Over US$ 200 billion in tariffs had been collected under IEEPA; the court did not rule on refunds
Connection to this news: The ruling immediately invalidated the legal basis for India's 25% reciprocal tariff, forcing both sides to recalibrate the interim deal that was premised on reducing that specific tariff.
Section 122 of the Trade Act of 1974 — Presidential Tariff Authority for Balance-of-Payments Deficits
After the Supreme Court ruling, the Trump administration pivoted to Section 122 of the Trade Act of 1974 as the legal basis for a new global tariff. This provision allows the President to impose an import surcharge of up to 15% when the US faces a "large and serious balance-of-payments deficit." Such tariffs under Section 122 are time-limited to a maximum of 150 days.
- Statutory basis: Section 122, Trade Act of 1974
- Maximum tariff rate under this provision: 15%
- Maximum duration: 150 days (Trump's tariffs effective February 24, 2026 — expire around late July 2026)
- Coverage: Global (not country-specific reciprocal tariffs)
- Legal challenge: Trade experts argue the condition (balance-of-payments deficit) is not met, as the US runs a capital account surplus
Connection to this news: India now faces a 15% global surcharge under Section 122 (plus ~3% MFN rate = ~18.4% total), which is close to the 18% rate the interim deal was targeting — making the value proposition of the deal less clear.
Most Favoured Nation (MFN) Principle in International Trade
The Most Favoured Nation (MFN) principle is a cornerstone of the WTO trading system. Under MFN treatment, any trade concession granted by one country to another must be extended to all WTO members on an equal basis. India's WTO-bound tariff rate (MFN rate) on most manufactured goods averages around 2-3%.
- Governed by: GATT Article I (for goods), GATS Article II (for services), TRIPS Article 4
- India's average applied MFN tariff: ~2-3% on most goods
- MFN waiver: Countries can deviate through Free Trade Agreements (FTAs) under GATT Article XXIV, or for developing countries under the Generalised System of Preferences (GSP)
- US removed India from GSP in 2019; restoration has been a recurring demand in bilateral trade talks
Connection to this news: With the 15% Section 122 tariff on top of the ~3% MFN rate, India's effective tariff exposure in the US market becomes ~18.4% — nearly matching what the proposed interim deal was trying to achieve, undermining the urgency of concluding the deal quickly.
India-US Bilateral Trade — Structure and Stakes
The United States is India's largest trading partner. India runs a trade surplus with the US, which has been a source of tension. The bilateral trade relationship spans goods (pharmaceuticals, IT services, textiles, gems, engineering goods) and services.
- India's exports to US: Pharmaceuticals, IT/software services, gems and jewellery, textiles, engineering goods
- Key exemption: Pharmaceuticals remain duty-free under the new global 15% tariff
- India's trade surplus with US: A persistent point of contention driving tariff negotiations
- Interim deal timeline (pre-ruling): Goyal indicated signing by March 2026, effective April 2026
- India was previously a GSP beneficiary until 2019 when the US revoked its GSP status
Connection to this news: The legal uncertainty around US tariff authority means India needs to carefully assess whether an interim deal locks it into unfavourable terms compared to the new, time-limited baseline tariff regime.
Key Facts & Data
- US SCOTUS ruling date: February 20, 2026
- Case: Learning Resources, Inc. v. Trump, 607 U.S. ___ (2026)
- Vote: 6-3 striking down IEEPA-based tariffs
- IEEPA: International Emergency Economic Powers Act, 1977
- Legal basis for new tariff: Section 122, Trade Act of 1974
- New global tariff rate: 15% (raised from an initial 10%)
- New tariff effective: February 24, 2026
- Duration of Section 122 tariffs: Maximum 150 days (~late July 2026)
- India's previous reciprocal tariff under IEEPA: 25%
- Interim deal target: ~18% effective rate
- India's combined tariff exposure now: 15% (Section 122) + ~3.4% (MFN) = ~18.4%
- Pharma sector: Exempt from the new 15% surcharge
- US India-GSP removal: 2019